Kappa free light chains (KFLC) are proteins found in the blood that are produced by the immune system. While they are typically present in very low levels, their presence can be an indicator of a number of health issues. Elevated KFLC levels can be an indication of multiple myeloma, a type of cancer that affects the bone marrow, or other conditions such as lymphoma or kidney disease. However, elevated KFLC levels can also be linked to other, less serious health issues that may not be immediately apparent. This article will explore the hidden link between elevated KFLC levels and unrecognized health issues.
KFLCs are proteins produced by the immune system that are found in the blood. They are part of a larger group of proteins known as immunoglobulins, which are responsible for helping the body fight off infections and other foreign substances. KFLCs are produced by B-cells, which are a type of white blood cell. They are made up of two different types of light chains, known as kappa and lambda, which are named after the Greek letters they resemble.
Elevated KFLC levels can be indicative of a number of health issues. The most common symptom of elevated KFLC levels is fatigue. Other symptoms can include loss of appetite, weight loss, bone pain, and increased risk of infection. If these symptoms are present, it is important to seek medical attention as soon as possible.
There are a number of possible causes of elevated KFLC levels. The most common cause is multiple myeloma, which is a type of cancer that affects the bone marrow. Other causes of elevated KFLC levels can include lymphoma, kidney disease, and certain medications. In some cases, elevated KFLC levels can also be caused by other, less serious health issues.
In addition to the more serious health issues linked to elevated KFLC levels, there are a number of unrecognized health issues that can be associated with them. One of the most common is anemia, which is a condition in which the body does not produce enough red blood cells. Anemia can cause fatigue, shortness of breath, and other symptoms. Other unrecognized health issues linked to elevated KFLC levels include autoimmune diseases, such as lupus and rheumatoid arthritis. These conditions can cause inflammation, joint pain, and other symptoms. Elevated KFLC levels can also be linked to certain types of kidney disease, such as glomerulonephritis.
Kappa free light chains are proteins found in the blood that are produced by the immune system. Elevated KFLC levels can be an indication of multiple myeloma, lymphoma, or other serious health issues. However, elevated KFLC levels can also be linked to other, less serious health issues that may not be immediately apparent. These unrecognized health issues can include anemia, autoimmune diseases, and certain types of kidney disease.
1.
The way that miR-377 inhibits cells that cause prostate cancer.
2.
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
3.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Survivors of childhood brain cancer are more likely to be held back in school
1.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
2.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
5.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation